Kireev Fedor D, Lopatnikova Julia A, Alshevskaya Alina A, Sennikov Sergey V
Laboratory of Molecular Immunology, Federal State Budgetary Scientific Institution "Research Institute of Fundamental and Clinical Immunology" (RIFCI), 630099 Novosibirsk, Russia.
Laboratory of Immune Engineering, Federal State Autonomous Educational Institution of Higher Education "I.M. Sechenov First Moscow State Medical University" under the Ministry of Health of the Russian Federation (Sechenov University), 119048 Moscow, Russia.
Biomolecules. 2025 May 12;15(5):709. doi: 10.3390/biom15050709.
Tumor necrosis factor (TNF) is a key immunoregulatory cytokine with a dual role in the host response to . While essential for granuloma formation, macrophage activation, and containment of latent infection, TNF can also contribute to tissue damage and immune pathology. This review systematically analyzes over 300 peer-reviewed studies published between 1980 and 2024, highlighting the molecular and cellular mechanisms of TNF action in tuberculosis (TB). Particular attention is given to TNF receptor signaling pathways, the balance between protective and pathological immune responses, and the modulation of TNF activity during anti-TNF therapy in patients with autoimmune diseases. We discuss how different TNF inhibitors vary in their capacity to interfere with host defense mechanisms, with monoclonal antibodies carrying a higher reactivation risk than receptor-based agents. To enhance conceptual clarity, we provide newly developed schematic representations that integrate current knowledge on TNF-driven immune dynamics, including its interaction with other cytokines, effects on granuloma stability, and role in intracellular bacterial control. Understanding the pleiotropic functions of TNF in tuberculosis pathogenesis is crucial for developing safe immunomodulatory strategies and optimizing the clinical management of patients at risk of latent TB reactivation.
肿瘤坏死因子(TNF)是一种关键的免疫调节细胞因子,在宿主对……的反应中具有双重作用。虽然TNF对于肉芽肿形成、巨噬细胞活化和潜伏感染的控制至关重要,但它也会导致组织损伤和免疫病理。本综述系统分析了1980年至2024年间发表的300多项同行评审研究,重点介绍了TNF在结核病(TB)中作用的分子和细胞机制。特别关注TNF受体信号通路、保护性和病理性免疫反应之间的平衡,以及自身免疫性疾病患者抗TNF治疗期间TNF活性的调节。我们讨论了不同的TNF抑制剂在干扰宿主防御机制的能力方面如何不同,单克隆抗体比基于受体的药物具有更高的再激活风险。为了提高概念清晰度,我们提供了新开发的示意图,整合了关于TNF驱动的免疫动力学的当前知识,包括其与其他细胞因子的相互作用、对肉芽肿稳定性的影响以及在细胞内细菌控制中的作用。了解TNF在结核病发病机制中的多效性功能对于制定安全的免疫调节策略和优化潜伏性TB再激活风险患者的临床管理至关重要。